Tag: Seborrheic Dermatitis

Progressive Facial Papules in  an African-American Patient: An Atypical Presentation of Seborrheic Dermatitis

Progressive Facial Papules in an African-American Patient: An Atypical Presentation of Seborrheic Dermatitis

| July 1, 2018

by Daniel P. Friedmann, MD, FAAD; Vineet Mishra, MD, FAAD; and Trevor Batty, BS  Dr. Friedmann is with the Westlake Dermatology Clinical Research Center at Westlake Dermatology & Cosmetic Surgery in Austin, Texas. Dr. Mishra is with the Division of Dermatology and Cutaneous Surgery at the University of Texas Health Science Center at San Antonio […]

Continue Reading

Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion

Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion

| January 1, 2018

by Deganit Barak-Shinar, PhD, and Lawrence J. Green, MD Dr. Barak-Shinar is Vice President of Clinical, Regulation and Quality Assurance at Kamedis Ltd. in Tel-Aviv, Israel. Dr. Green is  Associate Clinical Professor of Dermatology at The George Washington University School of Medicine in Washington, DC. Funding: This study was wholly funded by Kamedis Ltd. Disclosures: […]

Continue Reading

Dasatinib-induced Seborrheic Dermatitis-like Eruption

Dasatinib-induced Seborrheic Dermatitis-like Eruption

| July 1, 2017

by Ryan R. Riahi, MD, and Philip R. Cohen, MD Dr. Riahi is with DermSurgery Associates, Houston, Texas; and Dr. Cohen is with the Department of Dermatology, University of California San Diego, La Jolla, California. J Clin Aesthet Dermatol. 2017;10(7):23–27 Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to […]

Continue Reading

Adult Seborrheic Dermatitis: A Status Report on Practical Topical Management

| May 17, 2011 | 0 Comments

James Q. Del Rosso, DO, Dermatology Residency Program Director, Valley Hospital Medical Center, Las Vegas, Nevada Disclosure: Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott.

Continue Reading

Rational Management of Papulopustular Rosacea With Concomitant Facial Seborrheic Dermatitis-A Case Report

Rational Management of Papulopustular Rosacea With Concomitant Facial Seborrheic Dermatitis-A Case Report

| January 3, 2011 | 0 Comments

Wendy L. McFalda, DO; Heather L. Roebuck, BS, MSN, FNP-BC Clarkston Dermatology, Clarkston, Michigan Abstract Objective: To report a case of papulopustular rosacea with concomitant seborrheic dermatitis and discuss how signs and symptoms were ameliorated using a rational therapeutic approach. Design: Patient case report. Setting: Clinical practice. Participant: One male patient with rosacea, seborrheic dermatitis, […]

Continue Reading

Seborrheic Dermatitis and Malassezia species: How Are They Related?

Seborrheic Dermatitis and Malassezia species: How Are They Related?

| November 5, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD; Grace K. Kim, DO Introduction Seborrheic dermatitis (SD) is a common inflammatory dermatoses that may affect infants, adolescents, and adults of all ethnicities and races.[1,2] SD exhibits two incidence peaks, one during infancy, and the other during the fourth to sixth decades of life.[3] The prevalence of SD ranges […]

Continue Reading

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

| August 12, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD, Valley Hospital Medical Center, Las Vegas, Nevada Abstract Acne vulgaris is the most common disorder encountered in ambulatory clinical practice comprising 11.3 percent of office visits to dermatologists in 2005.[1] By comparison, eczematous dermatoses, psoriasis, and skin cancer accounted for 6.2, 3.5, and 10 percent of office visits, respectively.[1] […]

Continue Reading